Table 5.
Incidences and hazard ratios of arrhythmia for cervical spondylosis patients with and without treatment compared to patients without cervical spondylosis.
| Variable | N | Events | PYs | Rate # | Crude HR (95% CI) | Adjusted HR & (95% CI) | Crude HR (95% CI) | Adjusted HR & (95% CI) |
|---|---|---|---|---|---|---|---|---|
| Without cervical spondylosis | 22,236 | 537 | 137,401 | 3.91 | 1.00 | 1.00 | ||
| With cervical spondylosis | ||||||||
| Mild: cervical spondylosis no signs | 19,047 | 1335 | 107,982 | 12.4 | 3.13 (2.84, 3.47) *** | 3.32 (3.01, 3.68) *** | 1.00 | 1.00 |
| Moderate: cervical spondylosis receiving rehabilitation | 1996 | 67 | 14,352 | 4.67 | 1.22 (0.94, 1.57) | 1.94 (1.51, 2.51) *** | 0.40 (0.31, 0.50) *** | 0.61 (0.48, 0.78) *** |
| Severe: cervical spondylosis with neurological signs receiving spinal decompression | 1193 | 39 | 7935 | 4.91 | 1.27 (0.92, 1.75) | 1.84 (1.33, 2.55) *** | 0.41 (0.30, 0.56) *** | 0.58 (0.42, 0.79) *** |
Rate #, incidence rate, per 1000 person-years; Crude HR, relative hazard ratio; Adjusted HR &: mutually adjusted for age, sex, frequency of medical visits/per year, occupation, urbanization level, comorbidity of diabetes, hypertension, hyperlipidemia, CAD, stroke, CKD or ESRD, COPD, cancer, CHF, and medications of NSAID, beta blocker, propranolol, carvedilol, and bisoprolol by using Cox proportional hazards regression; *** p < 0.001.